Investor presentation
Logotype for Informa plc

Informa (INF) Investor presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Informa plc

Investor presentation summary

29 Oct, 2026

Growth platform and outlook

  • Structural tailwinds span face-to-face B2B events and specialist knowledge, supported by trusted content, first-party data, AI and digitisation.

  • Platform characteristics include 5%+ underlying revenue growth, 8m+ B2B audiences, 30m+ first-party data records and 14k+ specialist talent across 40 countries.

  • H1 2026 underlying revenue growth was 6.8% and underlying adjusted operating profit growth was 6.9%, excluding non-recurring data contracts; B2B Live Events and Academic Markets performed strongly.

  • H1 reported revenue was £2,064m vs £2,036m; adjusted operating profit was £548m vs £579m; adjusted diluted EPS was 26.6p vs 29.8p.

  • 2026 guidance reaffirmed: 6%± underlying revenue growth, including 7%+ for Live B2B Events and 4% for Academic Markets, plus double-digit underlying adjusted diluted EPS growth; interim dividend rose 6.9% to 7.48p and total buybacks set at £350m.

Pharma portfolio and reach

  • The pharma portfolio spans 36 years and reaches 323,000+ annual event attendees, 12,700+ exhibiting companies, 499,800+ professionals in its network and 153,900+ social media followers.

  • CPHI evolved from a pharma ingredients event to cover the supply chain from research through finished dosage, packaging and delivery; CPHI China and India also include PMEC machinery events.

  • Pharmapack serves packaging and drug delivery, with established European events and a Singapore launch; the portfolio includes events and specialist conferences across the Americas, Europe, Asia and the Middle East.

  • Recent initiatives include paid ticket models for CPHI Barcelona, CPHI & PMEC India and Pharmapack Europe, paid add-ons and upgrades, and four new zones at CPHI Milan.

CPHI Milan and future growth

  • CPHI Milan is positioned as a global meeting place for the pharma supply chain, with 60,000+ visitors, 2,900+ exhibitors, participants from 166+ countries and 300 expert speakers.

  • Four new zones covered AI & Tech, Cold Chain & Logistics, Contamination Control and Labelling; the event also included a co-located Sustainability Summit.

  • Planned growth levers include Lead Insights, optimised pass types, matchmaking, digital products and new event formats.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Informa